AURX
Price
$1.60
Change
-$0.00 (-0.00%)
Updated
Aug 7 closing price
Capitalization
74.93M
FENC
Price
$8.39
Change
+$0.32 (+3.97%)
Updated
Aug 8, 04:59 PM (EDT)
Capitalization
220.58M
90 days until earnings call
Interact to see
Advertisement

AURX vs FENC

Header iconAURX vs FENC Comparison
Open Charts AURX vs FENCBanner chart's image
Nuo Therapeutics
Price$1.60
Change-$0.00 (-0.00%)
Volume$325
Capitalization74.93M
Fennec Pharmaceuticals
Price$8.39
Change+$0.32 (+3.97%)
Volume$500
Capitalization220.58M
AURX vs FENC Comparison Chart in %
Loading...
AURX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FENC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AURX vs. FENC commentary
Aug 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURX is a Hold and FENC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 09, 2025
Stock price -- (AURX: $1.60 vs. FENC: $8.07)
Brand notoriety: AURX and FENC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURX: 1% vs. FENC: 69%
Market capitalization -- AURX: $74.93M vs. FENC: $220.58M
AURX [@Biotechnology] is valued at $74.93M. FENC’s [@Biotechnology] market capitalization is $220.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURX’s FA Score shows that 0 FA rating(s) are green whileFENC’s FA Score has 0 green FA rating(s).

  • AURX’s FA Score: 0 green, 5 red.
  • FENC’s FA Score: 0 green, 5 red.
According to our system of comparison, both AURX and FENC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURX’s TA Score shows that 7 TA indicator(s) are bullish while FENC’s TA Score has 5 bullish TA indicator(s).

  • AURX’s TA Score: 7 bullish, 3 bearish.
  • FENC’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, AURX is a better buy in the short-term than FENC.

Price Growth

AURX (@Biotechnology) experienced а +4.58% price change this week, while FENC (@Biotechnology) price change was -1.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.15%. For the same industry, the average monthly price growth was +6.53%, and the average quarterly price growth was +13.35%.

Reported Earning Dates

FENC is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+0.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FENC($221M) has a higher market cap than AURX($74.9M). FENC YTD gains are higher at: 27.690 vs. AURX (14.286). AURX has higher annual earnings (EBITDA): -2.48M vs. FENC (-10.34M). FENC has more cash in the bank: 22.7M vs. AURX (316K). AURX has less debt than FENC: AURX (132K) vs FENC (19.4M). FENC has higher revenues than AURX: FENC (30.9M) vs AURX (1.95M).
AURXFENCAURX / FENC
Capitalization74.9M221M34%
EBITDA-2.48M-10.34M24%
Gain YTD14.28627.69052%
P/E RatioN/A64.14-
Revenue1.95M30.9M6%
Total Cash316K22.7M1%
Total Debt132K19.4M1%
FUNDAMENTALS RATINGS
AURX vs FENC: Fundamental Ratings
AURX
FENC
OUTLOOK RATING
1..100
7258
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
89
Overvalued
PROFIT vs RISK RATING
1..100
71100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3643
P/E GROWTH RATING
1..100
10097
SEASONALITY SCORE
1..100
49n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FENC's Valuation (89) in the Biotechnology industry is in the same range as AURX (95) in the null industry. This means that FENC’s stock grew similarly to AURX’s over the last 12 months.

AURX's Profit vs Risk Rating (71) in the null industry is in the same range as FENC (100) in the Biotechnology industry. This means that AURX’s stock grew similarly to FENC’s over the last 12 months.

AURX's SMR Rating (100) in the null industry is in the same range as FENC (100) in the Biotechnology industry. This means that AURX’s stock grew similarly to FENC’s over the last 12 months.

AURX's Price Growth Rating (36) in the null industry is in the same range as FENC (43) in the Biotechnology industry. This means that AURX’s stock grew similarly to FENC’s over the last 12 months.

FENC's P/E Growth Rating (97) in the Biotechnology industry is in the same range as AURX (100) in the null industry. This means that FENC’s stock grew similarly to AURX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AURXFENC
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 11 days ago
77%
Bullish Trend 17 days ago
75%
Declines
ODDS (%)
Bearish Trend 9 days ago
74%
Bearish Trend 2 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
AURX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FENC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATOXF0.100.01
+9.63%
QUANTUM CRITICAL METALS CORP.
BNET0.170.01
+5.49%
Bion Environmental Technologies, Inc.
KNYJF60.05N/A
N/A
Kone Oyj
PTABF0.36N/A
N/A
Astra Agro Lestari TBK
QBCAF27.15-1.89
-6.51%
Quebecor Inc.

AURX and

Correlation & Price change

A.I.dvisor tells us that AURX and ALZN have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AURX and ALZN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURX
1D Price
Change %
AURX100%
N/A
ALZN - AURX
30%
Poorly correlated
-1.10%
VRAX - AURX
27%
Poorly correlated
+0.62%
NCNA - AURX
26%
Poorly correlated
-18.81%
FENC - AURX
23%
Poorly correlated
-1.10%
QNCX - AURX
22%
Poorly correlated
+2.41%
More